Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Evaluation of the Safety and Efficacy of a Biosimilar Abobotulinum Toxin Type a in Treating Moderate-To-Severe Glabellar Lines: A Non-Inferiority Double Blinded Randomized Controlled Trial
Navid Goodarzi
Navid Goodarzi

Assistant Professor of Pharmaceutics

Nanotechnology Research Center

Tehran University of Medical Sciences

All Documents
1. Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)], Journal of Drug Delivery Science and Technology (2023)
2. Engineered Plga Microspheres for Extended-Release of Naltrexone: In Vitro, In Vivo, and Ivivr, Pharmaceutical Development and Technology (2023)
3. Fabrication, Characterization and Evaluation of a New Designed Botulinum Toxin-Cell Penetrating Peptide Nanoparticulate Complex, DARU# Journal of Pharmaceutical Sciences (2023)
4. Current Status of Transarterial Chemoembolization (Tace) Agents in Hepatocellular Carcinoma Treatment, Journal of Drug Delivery Science and Technology (2022)
5. The Effects of a Combination Oral Spray (Mucosamin®) for the Prevention of Oral Mucositis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Double Blind Randomized Clinical Trial, Supportive Care in Cancer (2022)
6. Effects of Topical Vitamin E Mouthwash in Preventing Oral Mucositis in Allogenic Hematopoietic Stem Cell Transplant Patients: A Double-Blind, Placebo-Controlled Trial, Iranian Journal of Blood and Cancer (2021)
7. Glutamate-Urea-Based Psma-Targeted Plga Nanoparticles for Prostate Cancer Delivery of Docetaxel, Pharmaceutical Development and Technology (2021)
8. Does Pharmacodynamics of Drugs Change After Presenting Them As Na-Noparticles Like Their Pharmacokinetics?, Current Drug Targets (2020)
9. Preparation and Characterization of Albumin Nanoparticles of Paclitaxel-Triphenylphosphonium Conjugates: New Approach to Subcellular Targeting, Drug research (2020)
10. Synergistic Effect of Microrna and Albumin-Bound Nanoparticles for Inhibition of Glioblastoma Cancer Cell Proliferation, Brazilian Journal of Pharmaceutical Sciences (2020)
11. Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2, Journal of Drug Delivery Science and Technology (2018)
12. Preparation and Characterization of Self Nano-Emulsifying Drug Delivery System (Snedds) for Oral Delivery of Heparin Using Hydrophobic Complexation by Cationic Polymer of Β-Cyclodextrin, Drug Development and Industrial Pharmacy (2017)
13. Preparation of Human Serum Albumin Nanoparticles Using a Chemometric Technique, Journal of Nanostructure in Chemistry (2017)
14. Biotin/Folate-Decorated Human Serum Albumin Nanoparticles of Docetaxel: Comparison of Chemically Conjugated Nanostructures and Physically Loaded Nanoparticles for Targeting of Breast Cancer, Chemical Biology and Drug Design (2016)
15. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin, Journal of Pharmaceutical Sciences (2016)
16. Fabrication and Biological Evaluation of Chitosan Coated Hyaluronic Acid-Docetaxel Conjugate Nanoparticles in Cd44+ Cancer Cells, DARU# Journal of Pharmaceutical Sciences (2016)